Coalition for the Reversal of Breast Cancer Mortality in African American Women

A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond

Showing posts with label docetaxel. Show all posts
Showing posts with label docetaxel. Show all posts
Saturday, March 9, 2013

Synta announces results from Ganetespib Phase 2b trial on NSCLC

›
Published on September 29, 2012 at 5:14 AM   Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today ann...
Wednesday, February 27, 2013

INTERESTING ARTICLES. GO TO THEM!

›
1.Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal...
Monday, December 17, 2012

sCD163 and sTARC are disease response biomarkers for Hodgkin Lymphoma

›
sCD163 and sTARC are disease response biomarkers for Hodgkin lymphoma As published in Clinical Cancer Research , combined sCD163 and sTA...
›
Home
View web version

Steering Committee

Peggy Kankonde
View my complete profile
Powered by Blogger.